No results for ‘’
Coral Laboratories Ltd
NSE: BSE: 524506
₹585
(4.23%)
Fri, 18 Sept 2026, 00:22 pm
Market Cap (in Cr)209
PE Ratio10.88
Dividend0.26
Health Technology
Pharmaceuticals: Other
24.5KCompany History
1981
- Coral Laboratories P Ltd was incorporated.
1993
- The company was converted into a Public Ltd company.
2000
- The company received a WHO GMP Certificate for the Baroda Plant.
- The company received an ISO 9002 Certificate.
2001
- The company entered global marketing and started exporting.
- The company renewed its WHO GMP Certificate.
2002
- The company entered new global markets.
2003
- The manufacturing unit was approved by the Nigeria Food and Drug Administration.
2004
- The Daman manufacturing unit started manufacturing.
- The company established a Quality Management System compliant with ISO 9001:2008.
2005
- The company received a WHO GMP Certificate for the Daman Plant.
- The company started contract manufacturing for ACI Pharm and Medicale Pharmaceutique.
- The company received an ISO 9001-2008 Certificate for the Daman plant.
2006
- The company started the Dehradun plant.
2009
- The company received a WHO GMP Certificate for the Dehradun Plant.
2011
- Coral Laboratories Ltd recommended a dividend of 15%.
2012
- Coral Laboratories Ltd recommended a dividend of 15%.
2013
- Coral Laboratories Ltd recommended a final dividend of 15%.
2014
- Coral Laboratories Ltd recommended a dividend of 20%.